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Abstract
Background: Prescribing antimalarial medicines based on parasite confirmed diagnosis of malaria
is critical to rational drug use and optimal outcome of febrile illness. The impact of microscopy-
based versus clinical-based diagnosis of childhood malaria was assessed at primary health care
(PHC) facilities using a cluster randomized controlled training intervention trial.
Methods: Sixteen PHC facilities in rural Tanzania were randomly allocated to training of health
staff in clinical algorithm plus microscopy (Arm-I, n = 5) or clinical algorithm only (Arm-II, n = 5)
or no training (Arm-III, n = 6). Febrile under-five children presenting at these facilities were
assessed, treated and scheduled for follow up visit after 7 days. Blood smears on day 0 were only
done in Arm-I but on Day 7 in all arms. Primary outcome was antimalarial drug prescription. Other
outcomes included antibiotic prescription and health outcome. Multilevel regression models were
applied with PHC as level of clustering to compare outcomes in the three study arms.
Results: A total of 973, 1,058 and 1,100 children were enrolled in arms I, II and III, respectively,
during the study period. Antimalarial prescriptions were significantly reduced in Arm-I (61.3%)
compared to Arms-II (95.3%) and III (99.5%) (both P < 0.001), whereas antibiotic prescriptions did
not vary significantly between the arms (49.9%, 54.8% and 34.2%, respectively). In Arm-I, 99.1% of
children with positive blood smear readings received antimalarial prescriptions and so did 11.3% of
children with negative readings. Those with positive readings were less likely to be prescribed
antibiotics than those with negative (relative risk = 0.66, 95% confidence interval: 0.55, 0.72). On
day 7 follow-up, more children reported symptoms in Arm-I compared to Arm-III, but fewer
children had malaria parasitaemia (p = 0.049). The overall sensitivity of microscopy reading at PHC
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compared to reference level was 74.5% and the specificity was 59.0% but both varied widely
between PHCs.
Conclusion: Microscopy based diagnosis of malaria at PHC facilities reduces prescription of
antimalarial drugs, and appears to improve appropriate management of non-malaria fevers, but
major variation in accuracy of the microscopy readings was found. Lack of qualified laboratory
technicians at PHC facilities and the relatively short training period may have contributed to the
shortcomings.
Trial registration: This study is registered at Clinicaltrials.gov with the identifier NCT00687895.
Background
The annual burden of Plasmodium falciparum in sub-Saha-
ran Africa is estimated to be 365 million clinical episodes
resulting in over one million fatal cases, mostly in chil-
dren underfive years of age [1]. In Tanzania malaria con-
tinues to be the leading cause of morbidity and mortality
accounting for about 30% and 15% of all hospital admis-
sions and deaths, respectively [2].
Prompt and effective case management is critical for the
successful implementation of malaria control strategy [3].
Although over 80% of Tanzanians live within 5 kms of a
health facility providing malaria treatment, malaria case
management is often inadequate. In many primary health
care (PHC) facilities in Tanzania the quality of malaria
diagnosis and treatment suffers from inadequate clinical
examination, lack of diagnostic equipment, such as
microscopes, and non compliance with standard malaria
treatment guidelines [4-6]. Inappropriate drugs and inad-
equate treatment will cause higher morbidity and mortal-
ity from malaria [7], may also enhance the development
of drug resistance [8] and prevent optimal management of
fever illness other than malaria.
Most of malaria endemic African countries have adopted
the use of highly effective but expensive artemisinin-based
combination therapy (ACT). Restricted and better
directed treatment is increasingly advocated to prevent
drug resistance and reduce the costs of these drug combi-
nations [9,10]. Efforts have been made to improve the
management of illnesses in children, including malaria,
through the Integrated Management of Childhood Ill-
nesses (IMCI) strategy. However, the IMCI algorithm has
shown poor specificity in diagnosing malaria and causes
over-treatment with antimalarial drugs [11,12]. This was
less of a concern in the era of inexpensive chloroquine,
compared to the present use of expensive antimalarial
drugs like ACT. Improved diagnostic capacity potentially
includes the use of microscopy which still remains the
gold standard for laboratory diagnosis of malaria [5,6].
New diagnostic methods including malaria rapid tests
(RDTs) also need to be considered, but have limitations,
such as batch to batch quality variation, no parasite den-
sity determination, persistent positivity after treatment,
accuracy and cost [13,14].
The establishment and maintenance of reliable and effi-
cient malaria microscopy at PHC level requires organized
health system infrastructure, with functioning micro-
scopes, well trained health workers, regular provision of
reagents, supervision and quality control [15,16]. This
intervention study aimed to assess the impact of training
in microscopy and clinical diagnosis on antimalarial drug
prescriptions and health outcomes in childhood malaria
at PHC level.
Methods
Study area
The study was conducted in two neighbouring districts,
Kibaha and Bagamoyo, situated in the Coast region, north
of Dar es Salaam Tanzania, and with estimated popula-
tions of about 103,000 and 240,000, respectively. They
have similar geographical characteristics. Malaria trans-
mission is holoendemic, with some accentuation during
the rainy seasons in May-July and December to January.
Plasmodium falciparum is the dominant parasite species. In
Kibaha the government health facilities consist of one
hospital and 19 Primary Health Care (PHC) facilities (two
health centres and 17 dispensaries) and Bagamoyo has
one hospital and 41 PHC facilities (four health centres
and 37 dispensaries). Most PHC facilities are in the rural
areas where the majority of the population live. The
health staff includes assistant medical officers (AMO),
clinical officers (CO), assistant clinical officers (ACO),
mother and child health aides (MCHA), trained nurses,
nurse auxiliaries and laboratory assistants. They are super-
vised by the district medical officer (DMO) and other sen-
ior health officers from the district hospital.
PHC facilities receive medicines including antimalarial
drugs monthly through the essential drug program-Kit
system from the Medical Store Department (MSD), a
semi-autonomous institution located in part under the
Ministry of Health. Microscopes are available in health
centers and some dispensaries, but their use is limited
because of lack of qualified/skilled laboratory technicians.
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At the time of study, sulphadoxine/pyrimethamine (SP)
and amodiaquine (AQ) were the first- and second-line
treatments for uncomplicated malaria and quinine (QN)
the drug of choice for severe malaria.
Study design and allocation of health facilities
The study was designed as a cluster-randomized control-
led intervention evaluating two intervention packages
(Figure 1). PHC facilities were eligible for the study if they
were rural government owned; accessible by road during
rainy season; and within three hours by car from Muhim-
bili University College of Health Sciences (MUCHS), Dar
es Salaam. Out of 62 PHC facilities in the two districts, 31
qualified and visited by study team. The study objectives
and procedures were explained to the health workers and
a total of 16 PHC facilities consented and signed their
commitment to participate: three health centres (one in
Kibaha and two in Bagamoyo district) and 13 dispensaries
(five in Kibaha and nine in Bagamoyo district). The PHC
facilities were stratified into those with previous exposure
to IMCI training and those without and randomly allo-
cated either to training in clinical algorithm plus micros-
copy (Arm-I, n = 5), or clinical algorithm only (Arm-II, n
= 5), or to no training (Arm-III, n = 6). The remaining 15
PHC facilities did not participate because they were
engaged in other ongoing research activities.
Patients
Children attending the study PHC facilities during day-
time were enrolled if they fulfilled the following criteria:
a) under five years of age, b) fever (axillary temperature ≥
37.5°C) and/or history of fever in last two days, c) able to
return to the facility on day 7 after treatment or any other
day if symptoms were to worsen or recur and d) the
mother/guardian consented to participate. Patients with
severe illness requiring inpatient care according to the
IMCI guidelines were admitted or referred to the health
Study design and number of patients recruited to the study and follow up visits by type of interventionFigure 1
Study design and number of patients recruited to the study and follow up visits by type of intervention. PHC = 
primary health care. BS = blood smear.
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centres or the district hospitals. Both consultation and
treatments are provided free for under-five children.
Intervention packages
Clinical diagnosis of malaria
Based on national malaria treatment and the IMCI guide-
lines, a clinical training package was developed aiming at
improving the knowledge and the skills of the health
workers to clinically diagnose and treat malaria. The con-
tent of the package included (a) description of signs and
symptoms of malaria disease; (b) history taking relevant
to malaria and physical examination; (c) identification of
danger signs and severe illness for referral; (d) appropriate
treatment; (e) counselling patients on the use of drugs.
Microscopy diagnosis of malaria
Based on the World Health Organization (WHO) basic
malaria microscopy training manual [17], a training pack-
age on malaria microscopy was developed on how to (a)
make thick blood smears from febrile patients and stain
with Giemsa; (b) identify and count malaria parasites; (c)
maintain the microscope and store blood slides. Training
in haemoglobin (Hb) estimation using the Tallquist test
was also included in the package.
Training modules
The training for both packages included presentations of
theoretical information, brain storming and group discus-
sion. Clinical demonstrations were provided by the
research team illustrating how to take history, physical
examination, diagnosis, prescribing and counselling.
There were also clinical practice sessions with the health
care workers assessing patients under supervision with
individual feedback and practical sessions on malaria
microscopy which included blood smear preparation and
reading, parasite counting and artefact identification. A
pilot training programme conducted in rural Dar es
Salaam PHC facilities demonstrated its feasibility and
feedback from the participants was used to improve the
final training programme.
Health workers in Arm-I and II facilities received five-day
group training on management of malaria on clinical
basis and the health workers in Arm-I received an addi-
tional five-day group training in malaria microscopy. No
training was provided to those in Arm-III. In all three
arms, health workers were trained on how to fill the case
record forms and how to prepare malaria blood smears.
All health facility staff involved in the care of under-fives
were included in the training i.e. AMOs, COs, ACOs,
MCHAs, nurses, nurse assistants and laboratory assist-
ants/attendants. In Arm-I, microscopy was performed by
assistant laboratory technicians with one year training in
two PHC facilities (Chalinze and Mwanabwito) and by
the COs in three facilities (Kikongo, Mbwewe and Ubena
estate).
The training was held at each health facility during work-
ing hours; practical training was conducted in morning
sessions and the theoretical part in afternoons. The train-
ing was facilitated by two PhD research students (Ngasala
B and Mubi M) assisted by a senior laboratory technician
from MUCHS and supervised once a week by senior mem-
bers of the team. The project provided all study health
facilities with all supplies needed for making blood
smears. In addition each health facility in Arm-I was pro-
vided with one light microscopy and malaria microscopy
guidelines.
Data collection
Children presenting at the study facilities with fever were
enrolled in the study and information on age, sex, dura-
tion of fever, other presenting symptoms and body tem-
perature was recorded. Assessment of body temperatures
(axillary) were performed by using mercury thermome-
ters. In Arm-I, a thick blood smear for malaria was col-
lected from each patient and examined by the health
worker (first reading) and haemoglobin levels were esti-
mated using the Tallquist test. The collected blood smears
were forwarded weekly to MUCHS for second reading by
an experienced laboratory technician for malaria micros-
copy. In Arm-II and Arm-III, blood smears for malaria and
Tallquist test were not done on day 0. Diagnosis and pre-
scribed drugs (antimalarial drugs, antibiotics, antipyretic
and other drugs as per national treatment and IMCI guide-
lines) were recorded at the end of the consultations.
In all three arms, patients were scheduled for day 7 follow-
up visits and encouraged to report at any time prior to day
7 if necessary. The health workers assessed them for new
or persistent symptoms, any concomitant medication
taken and any adverse event perceived. In addition, thick
blood smears were taken during the follow-up visits and
examined by the second reader at MUCHS. Patients who
failed to attend the health facility for day 7 follow up were
visited at home to assess their health status and to identify
possible reasons for not attending scheduled follow up.
At the end of the study special interviews were conducted
with health workers in Arm-I to assess whether and under
what circumstances they prescribed antimalarial treat-
ment to patients with negative blood smear results.
Laboratory examinations
Thick blood smears were stained with 5% Giemsa for 20
minutes. Microscopy reading at PHC level included spe-
cies identification and parasite count. The parasite density
was estimated by counting the number of asexual para-
sites per 200 white blood cells and calculating parasites
Malaria Journal 2008, 7:199 http://www.malariajournal.com/content/7/1/199
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per μL, assuming a white cell count of 8,000 cells per μL.
A smear was declared negative if no asexual parasites were
seen after examining 100 high power fields. Every week an
experienced microscopist at MUCHS re-examined all
blood smears without knowledge of the first reading. The
result of the second reading was compared with the first
reading and if discordant results (positive vs. negative) or
even two fold difference in parasite density, a third deci-
sive microscopy reading, again blinded was to be done.
Using a Tallquist paper scale method, a drop of blood
absorbed on a test strip of filter paper was matched against
the scale standards by moving it up and down, to deter-
mine the equivalent Hb value. The Tallquist paper scale
has colours which range from yellow to brown in a scale
of 10%–100% which corresponds to Hb range from 1.58
to 15.8 g/dL.
Outcome measures
The primary outcome was the proportion of study chil-
dren receiving prescriptions of antimalarial drugs in the
respective arms. Secondary outcomes included prescrip-
tions of antibiotics, cost of drugs and health outcome of
the patients, i.e. the proportion of patients re-visiting the
health facility due to clinical complaints on days 1 to 6
and the proportion reporting symptoms on day 7 follow-
up. Full health improvement was determined by the pro-
portion of the study patients in each arm alive and with-
out complaints of fever or any other symptoms and
without parasitaemia on day 7. The cost of drugs was cal-
culated using price list from Medical Store Department.
Drug costs for each patient were calculated based on the
specific weight or age related drug regimen costs.
Sample size and statistical analysis
The prescription rate of antimalarial drugs was assumed to
be 90% in the control arm and the intervention package
in Arm-I was assumed to reduce this to 70%. The mini-
mum sample size for independent observations to give
90% power at a significance level of 5% was found to be
140 patients per comparative arm, when adjusted for mul-
tiple testing (Bonferroni). To account for secondary out-
comes, potential clustering at PHC level and a loss to
follow up, we decided to recruit 200 patients per facility
giving approximately 1,000 patients per arm. Compari-
sons of the differences in outcomes for the study arms
multilevel regression models were applied with PHC as
level of clustering (XTMIXED command in STATA version
10). In the result section 95% confidence intervals (CI)
are given and stated significances are on the 5% level.
Descriptive results within treatment arms were not
adjusted for clustering due to limited number of PHCs per
treatment arm.
Ethical considerations
Approval of the study was granted by the National Insti-
tute for Medical Research Tanzania and the Karolinska
Institutet (D-nr 03-712) ethical committees. Permission
to carry out the study was obtained from the district
health team, wards authorities and village leaders and
PHC facility workers. Informed written consent was
sought from parents/guardians of the under-five children.
Results
Baseline characteristics
A total of 3,131 children with fever were enrolled between
July 2003 and March 2004 (Figure 1). The baseline char-
acteristics of the enrolled children in the three arms are
summarized in Table 1. Age and sex distributions were
similar. Almost all patients in the three study arms had a
temperature measured and recorded during their visit on
day 0 (i.e. 99.6%, 96.1% and 96.8% in arms I, II and III,
respectively). Proportions of children with recorded tem-
perature ≥ 37.5°C were 50.4% in Arm-II compared to over
70% in the other two arms (p < 0.001). Msoga and
Lugoba health facilities mainly contributed to the low rate
of fever recorded in Arm-II. The distributions of medica-
tions reported taken by patients two weeks prior to visit at
health facilities were comparable across the study arms.
Prior self-treatment with antipyretics mostly paracetamol
was common (around 50%) while only 1% and 2% of
children reported medication with antimalarial drugs and
Table 1: Baseline characteristics of the study children enrolled in the three intervention arms
Characteristics Clinical algorithm + microscopy (Arm-I) Clinical algorithm (Arm-II) No special training (Arm-III)
Total children enrolled 973 1058 1100
Mean age in months (SD) 22.5 (14.9) 20.0 (14.8) 20.4 (14.3)
Males 472 (48.5) 555 (52.5) 563 (50.8)
Prior treatment taken*
Paracetamol 520 (53.4) 522 (49.3) 442 (40.1)
Sulfadoxine-pyrimethamine 10 (1.0) 9 (0.9) 8 (0.7)
Amodiaquine 7 (0.7) 12 (1.1) 5 (0.5)
Antibiotics 11 (1.1) 22 (2.1) 6 (0.6)
Values are numbers (percentages) unless stated otherwise
*14 days prior to enrolment
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antibiotics, respectively. Less than 1% (range 0.5%–0.6%)
of patients enrolled in each arm were referred on day 0 (n
= 6, Arm-II, n = 5, Arm-III, n = 6). In Arm-I, 361/934
(38.7%) children tested positive for malaria parasitaemia
according to the blood smear readings at MUCHS, the
geometric mean (range) was 5,247 (120–200,000) para-
sites/μL. In Arm-I, using Tallquist test, 665 children
(71.7%) were considered anaemic (Hb range 50%–70%),
and 172 (17.7%) severely anaemic (Hb < 50%).
Prescription of drugs
Table 2 summarizes drug prescription patterns in the
three study arms. The frequency of antimalarial prescrip-
tions was significantly lower in Arm-I (61.0%, CI: 51.6%,
70.3%) compared to Arm-II (95.2%, CI: 85.7%, 100%)
and control Arm-III (99.4%, CI: 90.9%, 100%) (both p <
0.001). SP, officially first-line antimalarial drug, was pre-
scribed to most malaria patients (range 73.8%–100%) in
14 study health facilities and AQ, officially second-line
antimalarial drug, was prescribed to most patients (48%
and 79%) in the two remaining health facilities (one in
Arm-I and another in Arm-III). Overall, in accordance
with Tanzania national treatment guidelines 76.7% of
antimalarial drugs were correctly (dosage and duration of
treatment) prescribed; 9.8% were under-dosed; 10.2%
were over-dosed; and in 3.3%, the treatment was correct
but the prescription indicated insufficient duration. There
was no significant difference in the proportion of antima-
larial drugs correctly prescribed in the three arms.
In all antibiotics were prescribed to 44.8% of all patients
but there was no significant difference in the proportion
of antibiotic prescriptions in the three arms (Table 2). The
antibiotics prescribed included tablets, capsules and syr-
ups (penicillin, ampicillin, amoxycillin, ampicloxacillin,
erythromycin and co-trimoxazole), injectables (gentamy-
cin, procaine and benzyl penicillin) and topical prepara-
tion (tetracycline eye ointment). The most common
antibiotics prescribed in all three arms were co-trimoxa-
zole and injectable procaine penicillin and benzyl penicil-
lin. Almost all patients in the three arms were prescribed
antipyretics (Table 2).
The average number of drugs per prescription was higher
in Arm-II compared to Arm-III (p = 0.003); other differ-
ences were not statistically significant. The average cost of
all drugs in Arm-III was 0.170 US$. This increased by 47%
in Arm-II (with clinical algorithm training) and by 18% in
Arm-I (with microscopy) (Table 2).
PHC versus MUCHS malaria microscopy
A total of 934 blood smears in Arm-I were re-examined at
the reference laboratory at MUCHS by the experienced
microscopist (Table 3). The first readings by the PHC
workers and and the second readings by MUCHS micro-
scopist agreed on a total of 607 (65%) blood smears, 269
positive smears (true positives) and 338 negative smears
(true negatives). All third microscopy readings for dis-
cordant results agreed with second reading results. Overall
sensitivity was 74.5% (CI: 69.8%, 78.7%) and specificity
was 59.0% (CI: 54.9%, 62.9%). A positive predictive
value of 53.4% (CI: 49.0%, 58.0%) and negative predic-
tive value of 78.6% (CI: 74.0%, 82.0%) were observed.
The accuracy of microscopy varied widely between the
study PHC facilities, e.g. the negative predictive values
were highest in Chalinze and Mwanabwito health facili-
ties whereas the positive predictive values were highest in
Kikongo and Mbwewe health facilities (Table 3). How-
ever, sensitivity of blood smear microscopy at PHC level
increased with increasing parasite density (Table 4).
In Arm-I and based on PHC facilities microscopy results,
antimalarial drugs were prescribed to nearly all patients (>
99%, range 97.7%–100%) with positive blood smears but
also to 50/442 (11.3%) with negative blood smears
(Table 5). Patients with negative blood smears at Kikongo
and Ubena health facilities were more likely to be pre-
scribed antimalarial drugs (20% and 35%, respectively)
Table 2: Medicines prescribed to febrile children attending the study PHC facilities in the three study arms.
Parameters Clinical algorithm + microscopy (Arm-I) Clinical algorithm (Arm-II) No special Training (Arm-III)
Total number of patients 973 1058 1100
Patients with prescriptions 944 (97.0) 1057 (99.9) 1097 (99.7)
Antimalarial drugs 576 (61.0) (CI: 51.6, 70.3) 1008 (95.2) (CI: 85.7, 100) 1091 (99.4) (CI: 90.9, 100)
Antibiotics 434 (45.9) (CI: 28.1, 63.7) 593 (54.8) (CI: 37.1, 72.6) 375 (34.2) (CI: 17.9,50.5)
Antipyretics 903 (95.7) 1027 (97.2) 1041(94.9)
Number of drugs prescribed 2306 2961 2718
Number of drugs per prescription 2.5 3.0 2.5
Average cost per antimalarial treatment 0.083 US$ 0.072 US$ 0.062 US$
Average cost of antimalarial drug/patient 0.050 US$ 0.070 US$ 0.062 US$
Average cost of all drugs/patient 0.200 US$ 0.250 US$ 0.170 US$
Values are numbers (percentages).
CI = (95% confidence interval).
1 US$ = 1000 Tanzanian shillings.
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whereas no or very few negative smear patients were
treated at Mwanabwito, Chalinze and Mbwewe health
facilities (0%, 1.1% and 3.6% respectively). According to
the health workers at Kikongo and Ubena health facilities,
patients with negative smears who received antimalarial
drugs were mainly attended by nurse auxillaries/assistants
when COs were away. All clinical staff stated they some-
times prescribe antimalarial drugs to patients despite neg-
ative microscopy results, particularly if a patient has high
fever and no other identified cause of fever.
Antibiotics were prescribed to 193/531 (36.3%) patients
in Arm-I with positive blood smears compared to 241/
442 (54.5%) patients with negative smears, indicating
that malaria patients were less likely to receive antibiotics
compared to patients without parasitaemia (relative risk =
0.66, CI: 0.55, 0.72). Of the 442 patients with negative
blood smears, 31% received neither antibiotic nor anti-
malarial drug i.e. only antipyretics and 4% had no record
of any drug prescription. The influence of clinical malaria
diagnosis on the antibiotic prescriptions could not be
compared meaningfully in Arms II and III because almost
all patients were considered as malaria and prescribed
antimalarial drugs. Based on the readings of day 0 blood
smears from Arm-I by the experienced microscopist at
MUCHS, antimalarial drugs were prescribed to about
80% of the patients with parasitaemia and 46% without
parasitaemia (Table 5).
Health outcomes
A total of 74 patients re-visited the health facilities
between days 1 to 6 with clinical complaints without sig-
nificant difference between the arms (Table 6). Between
day 1 and 7, 19 patients were referred to the district hos-
pitals due to severe conditions which included severe
malaria, severe pneumonia and severe anaemia. The fre-
quency of referral was highest in Arm-II (P < 0.022). Of
the referred patients, six patients re-attended between day
1 to 6 and 13 patients on day 7. Out of the 19 patients, 14
had received antimalarial treatment on day 0. One death
was reported in Arm-II; the child had developed signs of
severe malaria, four days after being prescribed SP and
was referred but died in the district hospital.
In Arm-I, 76 patients with positive blood smears accord-
ing to the experienced microscopist did not receive anti-
malarial drugs on day 0 (Table 5). These patients were
actively traced within 7 days of enrolment. One patient
returned to the health facility on day 1 of the study with
symptoms of severe malaria and anaemia, and was
referred to the district hospital. Thirteen patients returned
on day 2 of study with fever and parasitaemia and were
Table 3: Predictive values of blood smear (BS) results at Primary Health Care (PHC) facilities in the clinical algorithm + microscopy 
intervention arm
PHC Facilities BS positive rate (PHC microscopy 
reading) n/N (%)
BS positive rate (MUCHS 
reading) n/N (%)
Positive predictive Value % Negative predictive Value %
Chalinze 111/200 (55.5) 59/200 (29.5) 48.6 94.4
Ubena 140/180 (77.8) 83/176 (47.2) 51.1 66.7
Mbwewe 86/197 (43.7) 88/191 (46.1) 68.7 71.3
Kikongo 44/197 (22.3) 68/194 (35.1) 70.5 75.3
Mwanabwito 150/199 (75.4) 63/176 (36.4) 44.2 86.4
Total 531/973 (54.6)
(CI: 51.4, 57.7)
361/934 (38.7)*
(CI:35.6, 41.8)
53.4 (SD 12.1)
(CI: 49.0, 58.0)
78.6 (SD 11.4)
(CI: 74.0, 82.0)
CI = (95% confidence interval).
*39 Blood smear results missing/not done at reference laboratory by experienced microscopist
Table 4: Blood smear microscopy at Primary Health Care (PHC) facilities: sensitivity by parasite density in the clinical algorithm + 
microscopy intervention arm
Parasite density levels per μl blood Number of patients (N = 361) Sensitivity (%)
< 1000 63 49.2 (CI: 41.3, 57.1)
1,000 – 4,999 119 66.4 (CI: 57.9, 74.9)
5,000 – 10,0000 153 87.6 (CI: 82.4, 92.8)
> 100,000 26 96.2 (CI: 93.1, 99.2)
Total 361* 74.5 (CI: 67.6, 81.4)
CI = (95% confidence interval).
*934 blood smears were reviewed at reference level, 361 positive blood smears
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successfully treated for uncomplicated malaria. In the
remaining 62 patients, the fever resolved but parasitaemia
persisted until they eventually received antimalarial treat-
ment.
A total of 2,721 patients completed the follow up visit for
the health outcome assessment at day 7 (± 1 day). In addi-
tion, 406 patients who did not turn up on day 7 follow up
were visited in their homes on day 9 to 10. According to
the post-interventions follow up at home; over 97% were
reported to have recovered by day 7. The reasons provided
by parents/guardians for not attending regular day 7 fol-
low up included long distance to the facilities, travel or
moved away and a few had no reasons.
About 10% of patients in Arm-I and 5% of patients in
Arms-II and III had complaints of mainly fever, vomiting,
diarrhoea or cough, but there was no statistically signifi-
cant difference between the arms (Table 6). The frequency
of patients with positive blood smears was, however high-
est in the control Arm-III (17.2%) compared to the inter-
vention arms I (10.2%) and II (12.3%) (P = 0.049 and P
= 0.21 respectively). Out of 325 patients with positive
smears on day 7 from all three arms, 276 (84.9%) were
positive despite having been prescribed antimalarial drugs
on day 0. Types of antimalarial drugs taken by these
patients on day 0 included; SP 78.6%, AQ 18.5% and QN
2.9%. In Arm-I, of the 466 patients with positive smear
results, treated with antimalarial drugs on day 0 and re-
examined on day 7; 424 (91%) became parasite negative
("cured").
When defining full health improvement as absence of
fever or any symptoms or parasitaemia, the general recov-
ery rates on day 7 were 695/934 (74.4%) patients in Arm-
I, 649/826 (78.6%) in Arm-II and 650/961 (67.6%) in
Arm-III, but there was no statistically significant difference
between the arms.
Discussion
This study documents that the use of microscope for
malaria diagnosis significantly reduces prescriptions of
Table 5: Prescribed antimalarial drugs to febrile children in clinical algorithm + microscopy intervention arm in relation to blood 
smear (BS) microscopy results
BS results at PHC (N = 973) BS results at MUCHS (N = 934)*
BS positive BS negative BS positive BS negative
Antimalarial prescribed No (%) No (%) No (%) No (%)
Yes 526 (99.1) 50 (11.3) 285 (78.9) 264 (46.1)
No 3 (0.5) 365 (82.6) 68 (18.8) 289 (50.4)
No record 2 (0.4) 27 (6.1) 8 (2.2) 20 (3.5)
Total 531 442 361 573
PHC = Primary health care – laboratory attendant
MUCHS = Muhimbili University College of Health Sciences- experienced microscopist
* 39 BS results missing/not done at reference laboratory
Table 6: Health outcomes of the management of febrile childhood illness in the respective study Arms
Patient outcome Clinical algorithm + microscopy 
(Arm-I) n/N (%)
Clinical algorithm (Arm-II) n/N (%) No special training (Arm-III) n/N 
(%)
Re-attending on Day 1–6 with 
complaints
17/973 (1.7) 17/1058 (1.6) 40/1100 (3.6)
Re-attending on Day 1–6 with 
parasitaemia
8/17 (47.1) 10/17 (58.8) 24/40 (60)
Routine visit on Day 7 with 
complaints
94/934 (10.1) 47/826 (5.7) 41/961 (4.3)
Routine visit Day 7 with 
complaints and parasitaemia
19/94 (20) 7/47 (14.9) 10/41 (24.4)
Routine visit Day 7 with 
parasitaemia*
87/857 (10.2) 97/786 (12.3) 141/821 (17.2)
Referred Day 1–7 3/973 (0.3) 13/1058 (1.2) 3/1100 (0.3)
Death Day 1–7 0 1 0
*Blood smears missing from 77, 40 and 140 children in Arm-I, Arm-II and Arm-III respectively.
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antimalarial drugs when compared to use of clinical algo-
rithm alone. The majority of health workers in Arm-I
adhered to the blood smear results provided to them. In
contrast, the practice of giving antimalarial drugs to
patients with negative blood smears was significantly
more frequent in other studies [18-22]. One possible rea-
son for the added trust in the laboratory results in this
study maybe the involvement of the prescribers in the
microscopy training together with laboratory staff.
Prescription of antibiotics was also influenced by micros-
copy as patients in Arm-I with negative blood smears were
more likely to be prescribed antibiotics compared to
patients with positive blood smears. This is consistent
with findings from northeast Tanzania [18]. Restricting
antimalarial drugs to patients with positive blood smears
obviously enhances clinicians to consider antibiotics
treatment of potential bacterial diseases e.g. pneumonia
another important cause of infant and childhood mortal-
ity.
The findings from this study, further confirm the limited
usefulness of clinical algorithms alone in malaria diagno-
sis as has been shown earlier [11,12,23,24]. However the
algorithms seemed to improve the ability of health work-
ers to consider other alternative diagnosis, resulting in an
increase in frequency of antibiotic prescriptions in the
clinical diagnosis intervention arm compared to the con-
trol arm. This is in agreement with findings from Kenya
[12] and Uganda [25] where between 30% to 50% of chil-
dren were classified and treated according to IMCI as hav-
ing both pneumonia and malaria.
The current malaria treatment guidelines for Tanzania rec-
ommend any under-five child with fever or history of
fever within the last 24 hours without evidence of other
diseases should be treated for malaria even with a negative
blood smear/RDT for malaria parasites [26]. The rationale
for this policy is that in areas of very high malaria trans-
mission, malaria is the most likely cause of their illness
and withholding antimalarial drugs in this highly vulner-
able group will lead to poor outcomes. In this study, the
reduced prescription rate of antimalarial prescription in
Arm-I compared to arms II and III did not result in any
negative effect parasitologically or clinically. Patients in
Arm-I were not more likely to re-attend to the health facil-
ities between day 1–6 and even fewer patients had parasi-
taemia on day 7 compared to the other two arms. A reason
for this observation may be better adherence to treatment
in patients with malaria when they know that a parasito-
logical test has confirmed the diagnosis. Similar results
from Uganda showed that withholding antimalarial treat-
ment in febrile children with negative blood smears was
safe and saved 1,600 antimalarial treatments in 601 chil-
dren over an 18-month period [27].
There was sub-optimal quality of antimalarial drug pre-
scriptions among PHC health workers characterized by
incorrect doses, incorrect duration and high rate of amo-
diaquine use in some health facilities. These prescribing
patterns are similar to the results of previous cross sec-
tional studies in Tanzania [4,6]. These characteristics of
inappropriate drug use cause particular concern for the
development of resistance. Therefore, interventions to
improve rational use of antimalarial drugs in a sustainable
and cost-effective way are of crucial importance[28].
Clustering on PHC facilities was accounted for in the anal-
ysis and the relatively small number of PHC facilities ran-
domized to each arm might have reduced the power of the
study to show some important differences between study
arms. However, this was partly compensated for by
including a large number of patients. Selecting PHC facil-
ities that were geographically accessible from Dar es
Salaam might have introduced a selection bias. However
the selected facilities were not different from those not
included in the study in terms of number and quality of
staff and availability of drugs.
The overall accuracy of blood smear reading in this study
was relatively low with a large variation in the estimated
positive predictive values and negative predictive values in
different PHC facilities. False positive smears were fre-
quently reported, indicating a tendency among laboratory
workers to report a blood smear as positive when they are
in doubt. Also false negative smears were reported in
some patients with high parasite counts, maybe due to
insufficient reading time and poor smear quality. One
such child developed severe malaria. These reading inac-
curacies will result in delayed malaria diagnosis, severe ill-
ness and also undermine the management of non-malaria
associated illness. A national laboratory training pro-
gramme in Ghana demonstrated improvement in diag-
nostic accuracy of microscopy in PHC facilities [15]. The
partly different outcome to this study may have different
reasons such as relatively short period of training and dif-
ferences in qualifications of the laboratory technicians in
the two studies as well as increased work load to clinical
staff in PHC facilities which had no laboratory staff.
Conclusion
The findings of the present study indicate that microscopy
supported malaria diagnosis reduces over-prescription of
antimalarial drugs. However, the accuracy of the micros-
copy readings in this study was suboptimal despite the
extra training and supervision provided by the study per-
sonnel. Lack of qualified laboratory personnel at PHC
facilities in Tanzania and the relatively short training
period of the staff may have contributed to the shortcom-
ings. This calls for a simple malaria diagnostic tool for
PHC facilities and whether the role of RDTs may be more
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efficient than microscopy in such peripheral health care
settings needs to be investigated. Clearly laboratory tests
confirming the presence of malaria parasites will be
increasingly required, especially in the context of possible
future reduction in the incidence of malaria related dis-
ease [29,30]. This will influence the risks of not treating
patients with false negative smear readings and should be
weighed against benefits from restricted prescription of
antimalarial drugs, i.e. reduced drug costs and drug pres-
sure and improved management of alternative fever etiol-
ogies.
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